This diagnostic criteria should be applied in:
The criteria may only be applied to those patients in whom the symptoms are not better explained by an alternative diagnosis.
Four clinical and laboratory criteria along with optional ultrasound criteria can be applied to eligible patients to identify patients with PMR suitable for low-dose corticosteroid therapy
Points without ultrasound (US) (0-6) | Points with US (0-8) * | |
Morning stiffness duration >45 minutes | 2 | 2 |
Hip pain or limited range of motion | 1 | 1 |
Absence of RF or ACPA | 2 | 2 |
Absence of other joint involvement | 1 | 1 |
At least 1 shoulder with subdeltoid bursitis and/or biceps tenosynovitis and/or glenohumeral synovitis (either posterior or axillary) and at least 1 hip with synovitis and/or trochanteric bursitis | Not applicable | 1 |
Both shoulders with subdeltoid bursitis, biceps tenosynovitis, or glenohumeral synovitis | Not applicable | 1 |
A score of 4 or more is categorized as polymyalgia rheumatica (PMR) in the algorithm without ultrasound (US) and a score of 5 or more is categorized as PMR in the algorithm with US. CRP = C-reactive protein; ESR = erythrocyte sedimentation rate; RF = rheumatoid factor; ACPA = anti-citrullinated protein antibody;
*Optional ultrasound criteria.
Reference:
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.